AlphaLens
Research
研报Equal-weightTP $5200.00005月19日 · Morgan Stanley

Fujikura Announces New Mid-term Plan; Conservative Targets Raise Capacity Concerns

中文EN⚠ quality lint: see notes

Fujikura’s New Mid-Term Plan: Conservative Targets Mask Capacity Constraints, But New Product Optionality Offers a Hedge

Core Conclusion

Fujikura’s new mid-term plan (MTP) targets for F3/29 operating profit of ¥315bn and ROE of 28.5% appear conservative relative to prior execution. However, the binding constraint is not demand—it is internal production capacity. The company’s guidance for sustained external fiber procurement of ~15-20% annually and slowing SWR/WTC sales growth over F3/27-28 signal a structural ceiling on volume expansion. The market’s focus on target conservatism likely underestimates this capacity risk. Conversely, optionality from MMC ferrules and multi-core fusion splicers—both highlighted as growth drivers—may provide upside not captured in the plan’s baseline assumptions. At ¥4,695 (19 May close), with a target price of ¥5,200 (35.2x F3/28e EPS of ¥148) and an Equal-weight rating, the stock trades near fair value. Risk/reward is balanced unless capacity investment updates or new product traction shift the outlook.

What the Market May Be Underestimating

The market is likely pricing the MTP’s conservative targets without fully discounting the capacity bottleneck that underpins them. Two interrelated facts support this:

  • External fiber procurement is expected to remain at ~15-20% annually through the F3/27-29 period, meaning Fujikura must source roughly one-sixth to one-fifth of its fiber needs from third parties. This is not a temporary fix—it is a structural dependency that caps volume growth and limits margin expansion.
  • SWR/WTC sales growth is forecast to slow over F3/27-28, despite strong demand. The analyst explicitly notes this “could raise concerns within the stock market of potential production capacity constraints.”

Conversely, the market may also undervalue the upside from new product launches. The company plans to expand sales of MMC (multi-fiber push-on) ferrules and multi-core optical fiber fusion splicers. These are not captured in the MTP’s conservative baseline and could serve as incremental growth drivers, particularly if capacity constraints ease or if these products command higher margins.

Evidence Chain

1. Capacity Constraint: External fiber procurement is a structural anchor on volume and margin.

  • Fujikura explicitly guides for external fiber procurement of ~15-20% annually over the MTP horizon.
  • This implies the company cannot meet demand organically, surrendering volume and margin to external suppliers.
  • Investment implications: Revenue growth will be constrained by internal preform capacity, not demand. Upside from better demand or pricing cannot fully translate into output.

2. Slowing SWR/WTC sales growth signals a capacity ceiling, not demand weakness.

  • SWR/WTC (submarine and terrestrial cable) are core fiber-optic cable products. The company’s plan for sales growth to slow over F3/27-28 is a key indicator.
  • In a demand environment where fiber rollout remains robust, slowing growth is more likely capacity-driven than demand-driven.
  • Investment implications: Investors should monitor quarterly SWR/WTC sales trends as a real-time proxy for capacity utilization and bottlenecks.

3. New product optionality: MMC ferrules and multi-core splicers offer upside beyond the MTP baseline.

  • The company explicitly plans to expand sales of these products, and the analyst views them as a growth driver.
  • These products target higher-density optical networks and are not fully captured in the F3/27-29 plan assumptions.
  • Investment implications: If capacity constraints ease or these products ramp faster than expected, revenue and margin could exceed MTP targets. This is a catalyst that is not yet priced in.

Key Disagreements and Risks

Risk factors that could undermine the thesis:

  • Capacity expansion delays: Fujikura has announced ¥260bn investment in Japan/America, and the analyst believes preform capacity expansion is under consideration. If these investments are delayed or fail to materialize, external procurement dependency persists and growth remains capped.
  • Raw material cost spikes: Fiber production relies on silicon tetrachloride and other inputs. Sharp cost increases without full pass-through could compress margins, especially if external procurement limits pricing power.
  • Yen appreciation vs. the dollar: Fujikura generates significant overseas earnings. A stronger yen reduces reported revenue and margins, a risk explicitly listed by the analyst.
  • New product ramp disappointments: MMC ferrules and multi-core splicers may take longer to commercialize or may face slower adoption, limiting their contribution within the MTP horizon.

Valuation or Trading Implications

At ¥4,695, with a target price of ¥5,200 derived from a residual income model (10.0% cost of capital, 55% payout, ~18% mid-term growth, 3.7% terminal growth), the stock trades near our fair value estimate of 35.2x F3/28e EPS of ¥148. Given the Equal-weight rating, the risk/reward is balanced.

Key monitoring points for position sizing or entry/exit:

  • Progress on preform capacity investment disclosures—any concrete expansion plans would reduce the capacity constraint risk and likely lead to upward earnings revisions.
  • Quarterly SWR/WTC sales growth trends—slowing growth would confirm capacity constraints; acceleration would suggest investment is paying off.
  • New product revenue disclosures—MMC ferrules and multi-core splicer sales as a percentage of total revenue will indicate whether optionality is materializing.

An asymmetric opportunity exists only if capacity news or new product traction shifts the earnings trajectory meaningfully above the conservative MTP baseline. Absent that, the stock is fairly valued.

Appendix Data Summary

KPITarget
F3/28 Operating Profit¥264bn
F3/29 Operating Profit¥315bn
F3/29 ROE28.5%
F3/31 Operating Profit¥380bn
F3/36 Operating Profit¥580bn
Capital Allocation (F3/27-29 Cumulative)Amount
Operating Cash Flow Target¥620bn
Strategic/Growth Investments¥530bn
Shareholder Returns¥220bn
Japan/America Investment¥260bn (incl. potential preform capacity)

Related (同 ticker)